Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
about
Exosomes as a tumor immune escape mechanism: possible therapeutic implicationsThe Raji cell radioimmune assay for detecting immune complexes in human seraOverview of immunology of oral squamous cell carcinomaDepressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.Evidence that tumor antigens enhance tumor growth in vivo by interacting with a radiosensitive (suppressor?) cell population.Progress of immunotherapy in the treatment of malignant melanoma.Failure to detect soluble tumor associated antigen by radioimmunoassay in bovine lymphoma.Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysisBlastogenic suppression and alloantibody activity of sera from renal allograft recipientsIgG expression in human colorectal cancer and its relationship to cancer cell behaviors.Carcinoembryonic antigen (CEA)Inflammatory bowel disease associated circulating immune complexesSerial studies of autologous antibody reactivity to melanoma. Relationship to clinical course and circulating immune complexes.Prognostic role of antibody reactivity to melanomaAllograft tolerance: presumptive evidence that serum factors from tolerant animals that block lymphocyte-mediated immunity in vitro are soluble antigen-antibody complexesPromotion of tumor invasion by cooperation of granulocytes and macrophages activated by anti-tumor antibodies.Rheumatoid factor and tumor-host interaction.Therapeutic vaccination with tumor cells that engage CD137.Isolation and partial characterization of melanoma-associated antigens identified by autologous antibody.Immune response to a syngeneic rat tumour: evolution of serum cytotoxicity and blockade.Detection of circulating hepatoma D23 antigen and immune complexes in tumour bearer serumEffect of solubilized membrane antigens and tumour bearer serum on tumour growth in syngeneic hosts.Changes in host immunity following excision of a murine melanoma.Enhancement of syngeneic murine tumour transplantability by whole body irradiation--a non-immunological phenomenon.Studies on mouse Moloney virus induced tumours: II. Detection of p30 in the serum of mice with Moloney leukaemia by in vitro blocking of complement dependent antibody mediated cytotoxicity.Cellular immunity to encephalitogenic factor in man as measured by the macrophage migration inhibition test: the effects of serum.ACTH-like activity in immune complexes of patients with oat-cell carcinoma of the lung.Serological response to intracaecal injections of antigenic mouse tumour cells.Release of soluble "blocking" and "suppressor" factors from normal lymphocytes treated with RNA from spleens of tumour-bearing mice.Production of antibodies against antigens released from human pancreatic tumour xenograftsTumour-induced changes in murine lymphocyte profilesTumor immunity. An overviewCharacterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour systemEffect of pretreatment with immune serum on murine sarcoma virus (Moloney) tumour induction and growth.Immunologic and genetic factors influencing reproduction. A review.Immunotherapy and immunoprevention of cancer: where do we stand?Chronic allogeneic disease. 3. Genetic requirements for the induction of glomerulonephritisFeedback inhibition of specifically sensitized lymphocytes.Renal deposition of soluble immune complexes in mice bearing B-16 melanoma. Characterization of complexes and relationship to tumor progress.Effector cell blockade. A new mechanism of immune hyporeactivity induced by multivalent antigens
P2860
Q21245472-5DE3E962-3350-4F68-9AE2-5572226481D0Q24563492-B92C3A6D-E9BB-42EF-AA94-5EF3137F899EQ28079096-9FF2B24C-7076-47FD-A5DB-83C39F4E3485Q30442773-B33FE47C-CBF1-4909-8F56-E0EAC6B6A2ADQ33957527-28ACFE61-8133-4223-A0D8-18C2DFCDF6A1Q34085643-3684DCBD-D530-4FBF-A415-141B32392750Q34239215-C6F94DCC-9615-4390-9428-A71890AB4E5EQ34452449-3A2BEDE2-DFAC-4DE7-B39C-D886C242C5B1Q34460217-1020768C-F3C1-46A4-890F-B3050A6D494CQ34469524-331BD748-D1A5-4180-B77B-271C50E68B0BQ34475576-0BA9E261-79A2-42D2-B327-39A40C01DEBBQ34496939-04CF7A1E-CA36-4EA0-90B3-6F8CE8CED107Q34550480-BDA924DB-76BA-4D42-8C25-BEFAD038F63AQ34573286-139305A2-AB9C-49C6-B868-33E0DDAFEFE0Q34732776-1BDACE98-645E-4621-B317-3CC9EE7617D3Q34786193-AB043613-3507-4801-B222-28A597DFAFC8Q35006349-B3DB2058-D999-4CBE-BEAA-ED8A72F23168Q35071688-B2A60DBB-153F-4C8A-8EA3-BFE6AACEF15CQ35589402-AD667D67-53EF-4B55-A099-BE4D8243A280Q36040251-E25763C5-15AE-4C06-A33C-537DE0DF19E0Q36040723-5A0D8A70-7142-47A7-B7D1-811F73F512A7Q36041211-EF9AA1DE-DFDF-4611-9E5A-9C655E5F9459Q36041557-8F5AFA26-50F8-47EC-A0D4-8937BE997532Q36041650-E9862F8B-BD32-4F95-848B-00CFB72D8889Q36041669-0D0B209B-4A61-41C2-AAF3-B94BE7C626BBQ36041825-F0978579-4A41-4B2D-91B5-B92076332FCEQ36042741-C4484315-D6A3-403A-9118-02E7CE7200C5Q36042764-D84BC88D-D3CD-4FB1-B650-AFEA2EDE34F1Q36042912-70A6EF4A-73A7-4522-825E-CA4393BB8223Q36045612-C4C71310-CBE9-4092-B74E-E6B7ECC67F7FQ36046997-764EB555-3C16-47BD-8860-5E91AB016BADQ36058893-775CE2B4-396D-4D44-8390-6A86FAC15C5EQ36068873-90276C7E-F4A9-454E-BCC1-DC5FD626D35AQ36069027-6F4E67A3-6B7E-4FBA-9EB6-999BD034EE0FQ36092950-EF26EFCB-A0EE-4BB1-9FFA-A77BE3CC05B5Q36150524-F9B35879-6FA8-4391-BF6C-2938F0184DC6Q36271436-98B5FFA2-C3C3-44E4-AFC7-D7426E7CAE71Q36272995-AF737E98-75C5-4F59-B59D-55DA8D37AADFQ36273174-0F1ED188-6863-433C-B17A-A031C2ABE80FQ36273526-178D053E-D750-471B-827A-56954C187867
P2860
Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 1971
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suggestive evidence that the " ...... e antigen--antibody complexes.
@en
Suggestive evidence that the " ...... e antigen--antibody complexes.
@nl
type
label
Suggestive evidence that the " ...... e antigen--antibody complexes.
@en
Suggestive evidence that the " ...... e antigen--antibody complexes.
@nl
prefLabel
Suggestive evidence that the " ...... e antigen--antibody complexes.
@en
Suggestive evidence that the " ...... e antigen--antibody complexes.
@nl
P2093
P2860
P356
P1476
Suggestive evidence that the " ...... e antigen--antibody complexes.
@en
P2093
Hellström I
Hellström KE
P2860
P304
P356
10.1073/PNAS.68.6.1372
P407
P577
1971-06-01T00:00:00Z